Method for adjusting blood sugar through insulin
A technology of insulin and blood sugar, which is applied in the field of insulin adjustment of blood sugar, can solve problems such as difficulty in controlling blood sugar, loss of patients, poor blood sugar control, etc., and achieve the effect of reducing the incidence of hypoglycemia, shortening the time to reach the standard, and good blood sugar control
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0161] Example 1: The patient, female, 66 years old, hospital number 01147625, has been diabetic for 20 years, and her limbs have been numb for 3 years. She usually uses NovoSharp 30 combined with "Acarbose 50mg tid" to control blood sugar. Increased to above 30mmol / L, insulin dosage was used to adjust blood sugar, 10 days later blood sugar control reached the target, the final dosage was "NovoSharp 30: 20U-6U-15U, combined with acarbose: 50mg in the morning, 50mg at noon", during the treatment Blood sugar decreased steadily and hypoglycemia did not occur.
Embodiment 2
[0162] Example 2: The patient, male, 73 years old, hospital number 01147442, has been diabetic for eight years, and usually takes "Metformin Tablets 0.5 bid" to control blood sugar. The blood sugar control is not good, and the fasting blood sugar is about 17 mmol / l. After 11 days, the blood sugar control reached the standard, and the final dosage was "NovoSharp 30: 16U-O-18U, combined with acarbose: 50mg tid". During the treatment, the blood sugar decreased steadily and no hypoglycemia occurred.
Embodiment 3
[0163] Example 3: The patient, male, 69 years old, hospital number 01147499, had diabetes for five years, usually took "Gliclazide Sustained Release Tablets 30mg qd, Repaglinide 0.5mg bid" for treatment, poor blood sugar control, fasting blood sugar 16.0 mmol / L, glycosylated hemoglobin: 9.6mmol / L,
[0164] Insulin dosage form was used to adjust blood sugar, and the blood sugar control reached the standard after 7 days. The final dosage was "NovoSharp 30: 22U-O-18U, acarbose: 25mg in the morning, 50mg at noon, and 25mg in the evening". Hypoglycemia occurs.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com